# Study of Absorption, Metabolism and Excretion Following a Single Oral Dose of [14C]KWA-0711 to Healthy Male Subjects

> **NCT02434835** · PHASE1 · COMPLETED · sponsor: **Kissei Pharmaceutical Co., Ltd.**

## Conditions studied

- Healthy Male Subject

## Interventions

- **DRUG:** [14C]KWA-0711

## Key facts

- **NCT ID:** NCT02434835
- **Lead sponsor:** Kissei Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2015-05
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2016-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02434835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02434835, "Study of Absorption, Metabolism and Excretion Following a Single Oral Dose of [14C]KWA-0711 to Healthy Male Subjects". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02434835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
